Promising Results in Stroke Treatment Using Cord Blood Stem Cells

Strategic Insights -

Researchers from the Medical College of Georgia (MCG) and the University of South Florida (USF) have made a groundbreaking discovery in the treatment of stroke, utilizing cord blood stem cells in conjunction with a temporary breach of the brain's protective barrier. According to their study published in the October issue of American Heart Association's journal, Stroke, stem cells taken from umbilical cord blood and administered intravenously alongside a certain drug can significantly reduce stroke size and damage. This therapy showed promising results, decreasing stroke size by 40% and reducing resulting disability.

Key Takeaways:

  • The study, conducted by the Medical College of Georgia and the University of South Florida, demonstrated that cord blood stem cells can dramatically reduce stroke size and damage when administered in conjunction with a drug that temporarily breaches the brain's protective barrier.
  • When used in the first hours and days following a stroke, this therapy reduced stroke size by 40% and significantly reduced resulting disability.
  • The study's lead neuroscientist, Paul R. Sanberg, highlighted that umbilical cord blood cells do not need to become new brain cells to provide protection, emphasizing the therapeutic potential of these cells.
  • Cryo-Cell International, Inc., Affiliate Saneron CCEL Therapeutics, Inc., collaborated with the researchers on the study, underscoring the potential for future human therapeutic applications.
  • The findings suggest that cord blood banking may become increasingly important as this breakthrough research offers promising evidence for potential future human therapeutic value.

Statistics:

  • 40% decrease in stroke size observed when cord blood stem cells were administered in conjunction with a temporary breach of the brain's protective barrier.
  • 40% reduction in resulting disability associated with the use of cord blood stem cells in the first hours and days following a stroke.

Sources:

  • "Cryo-Cell International Announces Promising Research Findings Using Cord Blood Stem Cells in Conjunction with Stroke" (NewsRx.com & NewsRx.net, 2004 NOV 8)
  • "Stroke" Journal, October issue (American Heart Association)
  • Interview with Paul R. Sanberg, Neuroscientist, University of South Florida
  • Interview with Mercedes Walton, Chairman and Interim CEO, Cryo-Cell International, Inc.